Literature DB >> 15972220

Unilateral retrobulbar optic neuritis due to varicella zoster virus in a patient with AIDS: a case report and review of the literature.

Joe Zhaoping Liu1, Patricia Brown, Alex Tselis.   

Abstract

Unilateral retrobulbar optic neuritis developed in a 43-year-old man with acquired immune deficiency syndrome (AIDS). This was secondary to varicella zoster virus (VZV) as confirmed by cerebrospinal fluid (CSF) polymerase chain reaction (PCR) detection of VZV in the cerebrospinal fluid. There was no typical cutaneous infection and no evidence of retinitis. The onset of unexplained visual loss due to optic neuritis in HIV positive individuals may be due to VZV infection. Prompt recognition, and early intervention with antiVZV therapy may preserve vision. Retrobulbar optic neuritis secondary to VZV infection should be considered in immunocompromised patients even in the absence of cutaneous or retinal lesions. Previous cases are reviewed and the varied nature of viral transport in the nervous system is noted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972220     DOI: 10.1016/j.jns.2005.05.005

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Encephalomyelitis After Varicella Zoster Reactivation in an Immunocompromised Patient.

Authors:  Lindsay P Busby; Steven M Herron; Jason F Talbott; Alina Uzelac; Bhavya Rehani
Journal:  Neurohospitalist       Date:  2017-05-11

Review 2.  Determinants of neurological syndromes caused by varicella zoster virus (VZV).

Authors:  Peter Ge Kennedy; Trine H Mogensen
Journal:  J Neurovirol       Date:  2020-06-03       Impact factor: 2.643

3.  Bilateral Retrobulbar Optic Neuritis Caused by Varicella Zoster Virus in a Patient with AIDS.

Authors:  Jose F Duda; Jose G Castro
Journal:  Br J Med Med Res       Date:  2014-11-11

4.  Varicella zoster virus-associated neuroretinitis.

Authors:  Wei-Shan Tsao; Ming-Shan He; Rong-Kung Tsai
Journal:  Taiwan J Ophthalmol       Date:  2014-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.